/content/dam/www/people-profile-photos/s/michael-schweizer/provider-michael-schweizer-directory-1x.jpg
/content/dam/www/people-profile-photos/s/michael-schweizer/provider-michael-schweizer-directory-2x.jpg
Schweizer
Michael Schweizer, MD

Michael Schweizer, MD

Medical Oncology

  • Genitourinary Oncology Clinical Research Director, Fred Hutch
  • Interim Director, Phase 1 Clinical Trials Program, Fred Hutch
  • Professor, Clinical Research Division, Fred Hutch
  • Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
  • Professor, Division of Hematology and Oncology, University of Washington School of Medicine
Request an Appointment

About

Dr. Michael Schweizer is a board-certified medical oncologist and researcher at Fred Hutch. He treats genitourinary cancers and leads research to develop new therapies, including clinical trials of high‑dose testosterone for people with advanced prostate cancer.

Background

Dr. Schweizer cares for patients with genitourinary cancers, including bladder, prostate and testicular, while leading research focused on improving treatment options for these diseases.

His research aims to develop new drugs and therapies and to move promising advances from the lab into patient care. He leads several translational clinical trials, which are studies designed to bring research discoveries into the clinic more quickly, including trials evaluating high‑dose testosterone as a treatment approach for advanced prostate cancer.

Area of Clinical Practice
Genitourinary cancers

“My goal is to provide patient care that is driven by science combined with compassion and empathy.”

— Dr. Schweizer

Why do you practice oncology?

Michael Schweizer, MD, decided to work in health care because he wanted to feel intellectually challenged in his career and, more importantly, he wanted to do something that would allow him to help people. Medicine was the perfect fit. “Early on in my training, I realized that you often see the best in people when they are faced with a cancer diagnosis,” Dr. Schweizer said. “The hope that my patients have in spite of being diagnosed with such serious illnesses is inspiring. It’s my patients’ hope that motivates me and makes me want to be a part of working toward cures.”

Dr. Schweizer’s research involves translational genitourinary cancer. “My goal is to help reduce the morbidity and mortality associated with diseases like prostate cancer through developing novel drug therapies. Cancer is a formidable foe, but one that I believe we can vanquish. I hope to be a part of bringing the dream of a world without cancer into reality. I hope to see cancer cured in my lifetime.” 

Provider Background

Area of Clinical Practice
Genitourinary cancers

Diseases Treated

Bladder Cancer

Prostate Cancer

Penile Cancer

Testicular Cancer

Research Interests

Translational prostate cancer research

Novel therapeutics/drug development

Languages

English

Education and Experience

Fellowship, Johns Hopkins University

Residency, University of Chicago

MD, Temple University School of Medicine

BS, Chemical Engineering, University of Delaware

Board Certification

Internal Medicine, 2011, Medical Oncology, 2013, American Board of Internal Medicine

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your physician can decide if a study is right for you. 

Find a Clinical Trial Led by Dr. Schweizer

Publications

Many of our Fred Hutch physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch physician has written. 

View Publications by Dr. Schweizer

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders. 

Meet Other Providers

Insurance

Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

More About Insurance

Stories

All news
ASCO Young Investigator Award winners showcase the breadth and depth of Fred Hutch research
ASCO Young Investigator Award winners showcase the breadth and depth of Fred Hutch research Hematology-oncology fellows and faculty receive $50,000 each toward early-career projects May 28, 2026
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards Three-year projects explore epigenetics to make new therapies or make existing therapies work better May 13, 2026
‘Good cancer’? Views vary on a sunny phrase
‘Good cancer’? Views vary on a sunny phrase Many patients and doctors refuse to apply the ‘g’ word to highly curable cancers, but some survivors draw hope from the ‘good’ November 10, 2016